Implantica announces excellent data from an independent study of 158 RefluxStop™ patients from two centers in Germany – presented at the AUGIS meeting in UK

VADUZ, Liechtenstein, Sept. 18, 2024 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, reports that the study “Pooled two-year results of the novel RefluxStop implantable device in management of gastroesophageal…